Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cells

Abstract Background Though (1S, 3R)-RSL3 has been used widely in basic research as a small molecular inducer of ferroptosis, the toxicity on normal cells and poor pharmacokinetic properties of RSL3 limited its clinical application. Here, we investigated the synergism of non-thermal plasma (NTP) and...

Full description

Bibliographic Details
Main Authors: Shengjie Peng, Guodong Chen, K. N. Yu, Yue Feng, Lele Zhao, Miaomiao Yang, Wei Cao, Waleed Abdelbagi Ahmed Almahi, Mingyu Sun, Yuan Xu, Ye Zhao, Cheng Cheng, Fengqin Zhu, Wei Han
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Cell Communication and Signaling
Subjects:
Online Access:https://doi.org/10.1186/s12964-023-01382-z
_version_ 1797273829875122176
author Shengjie Peng
Guodong Chen
K. N. Yu
Yue Feng
Lele Zhao
Miaomiao Yang
Wei Cao
Waleed Abdelbagi Ahmed Almahi
Mingyu Sun
Yuan Xu
Ye Zhao
Cheng Cheng
Fengqin Zhu
Wei Han
author_facet Shengjie Peng
Guodong Chen
K. N. Yu
Yue Feng
Lele Zhao
Miaomiao Yang
Wei Cao
Waleed Abdelbagi Ahmed Almahi
Mingyu Sun
Yuan Xu
Ye Zhao
Cheng Cheng
Fengqin Zhu
Wei Han
author_sort Shengjie Peng
collection DOAJ
description Abstract Background Though (1S, 3R)-RSL3 has been used widely in basic research as a small molecular inducer of ferroptosis, the toxicity on normal cells and poor pharmacokinetic properties of RSL3 limited its clinical application. Here, we investigated the synergism of non-thermal plasma (NTP) and low-concentration RSL3 and attempted to rise the sensitivity of NSCLC cells on RSL3. Methods CCK-8 assay was employed to detect the change of cell viability. Microscopy and flowcytometry were applied to identify lipid peroxidation, cell death and reactive oxygen species (ROS) level respectively. The molecular mechanism was inspected with western blot and RT-qPCR. A xenograft mice model was adopted to investigate the effect of NTP and RSL3. Results We found the synergism of NTP and low-concentration RSL3 triggered severe mitochondria damage, more cell death and rapid ferroptosis occurrence in vitro and in vivo. NTP and RSL3 synergistically induced xCT lysosomal degradation through ROS/AMPK/mTOR signaling. Furthermore, we revealed mitochondrial ROS was the main executor for ferroptosis induced by the combined treatment. Conclusion Our research shows NTP treatment promoted the toxic effect of RSL3 by inducing more ferroptosis rapidly and provided possibility of RSL3 clinical application. Graphical Abstract Video Abstract
first_indexed 2024-03-07T14:49:50Z
format Article
id doaj.art-ab656864d2554883bb46cb26951e27c9
institution Directory Open Access Journal
issn 1478-811X
language English
last_indexed 2024-03-07T14:49:50Z
publishDate 2024-02-01
publisher BMC
record_format Article
series Cell Communication and Signaling
spelling doaj.art-ab656864d2554883bb46cb26951e27c92024-03-05T19:47:11ZengBMCCell Communication and Signaling1478-811X2024-02-0122111410.1186/s12964-023-01382-zSynergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cellsShengjie Peng0Guodong Chen1K. N. Yu2Yue Feng3Lele Zhao4Miaomiao Yang5Wei Cao6Waleed Abdelbagi Ahmed Almahi7Mingyu Sun8Yuan Xu9Ye Zhao10Cheng Cheng11Fengqin Zhu12Wei Han13Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesDepartment of Physics, City University of Hong KongAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesTeaching and Research Section of Nuclear Medicine, School of Basic Medical Sciences, Anhui Medical UniversityInstitute of Plasma Physics, Hefei Institutes of Physical Science, Chinese Academy of SciencesHefei Cancer Hospital, Chinese Academy of SciencesAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of SciencesAbstract Background Though (1S, 3R)-RSL3 has been used widely in basic research as a small molecular inducer of ferroptosis, the toxicity on normal cells and poor pharmacokinetic properties of RSL3 limited its clinical application. Here, we investigated the synergism of non-thermal plasma (NTP) and low-concentration RSL3 and attempted to rise the sensitivity of NSCLC cells on RSL3. Methods CCK-8 assay was employed to detect the change of cell viability. Microscopy and flowcytometry were applied to identify lipid peroxidation, cell death and reactive oxygen species (ROS) level respectively. The molecular mechanism was inspected with western blot and RT-qPCR. A xenograft mice model was adopted to investigate the effect of NTP and RSL3. Results We found the synergism of NTP and low-concentration RSL3 triggered severe mitochondria damage, more cell death and rapid ferroptosis occurrence in vitro and in vivo. NTP and RSL3 synergistically induced xCT lysosomal degradation through ROS/AMPK/mTOR signaling. Furthermore, we revealed mitochondrial ROS was the main executor for ferroptosis induced by the combined treatment. Conclusion Our research shows NTP treatment promoted the toxic effect of RSL3 by inducing more ferroptosis rapidly and provided possibility of RSL3 clinical application. Graphical Abstract Video Abstracthttps://doi.org/10.1186/s12964-023-01382-zNon-thermal plasmaFerroptosisLung cancerRSL3 clinical application
spellingShingle Shengjie Peng
Guodong Chen
K. N. Yu
Yue Feng
Lele Zhao
Miaomiao Yang
Wei Cao
Waleed Abdelbagi Ahmed Almahi
Mingyu Sun
Yuan Xu
Ye Zhao
Cheng Cheng
Fengqin Zhu
Wei Han
Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cells
Cell Communication and Signaling
Non-thermal plasma
Ferroptosis
Lung cancer
RSL3 clinical application
title Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cells
title_full Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cells
title_fullStr Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cells
title_full_unstemmed Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cells
title_short Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cells
title_sort synergism of non thermal plasma and low concentration rsl3 triggers ferroptosis via promoting xct lysosomal degradation through ros ampk mtor axis in lung cancer cells
topic Non-thermal plasma
Ferroptosis
Lung cancer
RSL3 clinical application
url https://doi.org/10.1186/s12964-023-01382-z
work_keys_str_mv AT shengjiepeng synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT guodongchen synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT knyu synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT yuefeng synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT lelezhao synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT miaomiaoyang synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT weicao synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT waleedabdelbagiahmedalmahi synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT mingyusun synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT yuanxu synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT yezhao synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT chengcheng synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT fengqinzhu synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells
AT weihan synergismofnonthermalplasmaandlowconcentrationrsl3triggersferroptosisviapromotingxctlysosomaldegradationthroughrosampkmtoraxisinlungcancercells